Preventive Medicine Doctors in Peterson Afb, CO Accepting Medicare
3 Preventive Medicine doctors found. Showing 1 - 3
 Cristina Cosner, DO Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 559 Vincent St, Attn: 21 Mdos/sgof - Flight Med, Peterson Afb, CO 80914 Phone: 719-526-2273 Fax: 877-813-1756 |
 Dr. John Scott Brooks, M.D., MPH Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 559 Vincent St, Attn: 21 Amds/sgpf - Aerosp Medicine, Peterson Afb, CO 80914 Phone: 719-556-2273 Fax: 866-867-7926 |
Dr. Bryan Thomas Alvarez, MD, MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 559 Vincent St, Attn: 21 Mdos/sgof - N&nc Sg, Peterson Afb, CO 80914 Phone: 719-526-2273 Fax: 866-867-7926 |
News Archive
New clinical practice guidelines on sleep apnea, driving risk on non-commercial drivers
The American Thoracic Society has released new clinical practice guidelines on sleep apnea, sleepiness, and driving risk on non-commercial drivers.
Deaths from insulin overdose at Chicago hospital raise suspicion
The deaths of two elderly patients in Chicago hospital have prompted a police investigation.
Research roundup: Crowded emergency departments, expensive HIV drugs, high deductible insurance plans
Skin In The Game: How Consumer-Directed Plans Affect The Cost And Use Of Health Care - Consumer-directed health plans, which feature lower premiums and higher deductibles than traditional plans, are designed to reduce costs by discouraging unnecessary care. This brief describes a study of more than 800,000 households that switched from a traditional employer-based plan to a consumer-based plan.
New heart-powered pacemakers may be on the horizon
The implantable pacemaker, a medical marvel that has extended millions of lives since its invention nearly 60 years ago, is getting a 21st century makeover.
Receptos raises $25 million through Series A financing
Receptos, Inc., a privately held biopharmaceutical company, announced the closing of a two-tranche $25 million Series A financing. The company is focused on identifying and developing best- and first-in-class GPCR therapeutic candidates through information-driven drug discovery, including GPCR structure. Investors include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.
› Verified 9 days ago
Family Medicine
Pediatrics
Psychiatry & Neurology
Preventive Medicine
Dermatology
Orthopaedic Surgery